Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)

Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis

(2012) Pierre–Emmanuel Rautou et al.   GASTROENTEROLOGY

Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation

(2012) M. L. RAND et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers

(2012) Jeroen F. van Velzen et al.   THROMBOSIS RESEARCH

Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species

(2012) Hartmut Jaeschke et al.   Transplantation Reviews

Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells

(2010) Miroslaw Kornek et al.   HEPATOLOGY

Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation

(2010) Jan Schulte Am Esch et al.   PLATELETS

The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair

(2009) Brigitte Vollmar et al.   PHYSIOLOGICAL REVIEWS

20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction

(2008) I-Jung Tsai et al.   FREE RADICAL BIOLOGY AND MEDICINE

HDL is the major lipoprotein carrier of plasma F2-isoprostanes

(2008) Julie M. Proudfoot et al.   JOURNAL OF LIPID RESEARCH